Mots-clés
> MYOBASE > BIOLOGIE > biologie par discipline > génétique > génétique formelle > corrélation génotype-phénotype
corrélation génotype-phénotypeSynonyme(s)genotype-phenotype correlationVoir aussi |
Documents disponibles dans cette catégorie (1082)
Article
Baumbach-Reardon L ; Hunter JM ; Ahearn ME ; Pfautsch M | 29/07/2021Initial Posting: October 30, 2008; Last Update: July 29, 2021.Article
Handunnetthi L ; Knezevic B ; Kasela S ; Burnham KL ; Milani L ; Irani SR ; Fang H ; Knight JC | United States | 19/07/2021Article
Article
Article
Weber F | 01/07/2021Initial Posting: July 18, 2003; Last Update: July 1, 2021. Clinical characteristics. Hyperkalemic periodic paralysis (hyperPP) is characterized by attacks of flaccid limb weakness (which may also include weakness of the muscles of the eyes[...]Article
Sivera R ; Lupo V ; Frasquet M ; Argente-Escrig H ; Alonso Perez J ; Diaz-Manera J ; Querol L ; García-Romero MDM ; Pascual SI ; Garcia Sobrino T ; Paradas C ; Vazquez-Costa JF ; Muelas N ; Millet E ; Vilchez JJ ; Espinos C ; Sevilla T | England | 30/06/2021Article
Uchôa Cavalcanti EB ; Santos SCL ; Martins CES ; de Carvalho DR ; Rizzo IMPO ; Freitas MCDNB ; da Silva Freitas D ; de Souza FS ; Junior AM ; do Nascimento OJM | United States | 30/06/2021Article
Article
Van Lent J ; Verstraelen P ; Asselbergh B ; Adriaenssens E ; Mateiu L ; Verbist C ; De Winter V ; Eggermont K ; van den Bosch L ; De Vos WH ; Timmerman V | England | 15/06/2021Article
Georganopoulou DG ; Moisiadis VG ; Malik FA ; Mohajer A ; Dashevsky TM ; Wuu ST ; Hu CK | 10/06/2021Article
Subréville M ; Bonello-Palot N ; Yahiaoui D ; Beloribi-Djefaflia S ; Fernandes S ; Stojkovic T ; Cassereau J ; Pereon Y ; Echaniz-Laguna A ; Violleau MH ; Soulages A ; Louis SL ; Masingue M ; Magot A ; Delmont E ; Sacconi S ; Adams D ; Labeyrie C ; Genestet S ; Noury JB ; Chanson JB ; Levy N ; Juntas-Morales R ; Tard C ; Sole G ; Attarian S | England | 01/06/2021Article
Kumutpongpanich T ; Ogasawara M ; Ozaki A ; Ishiura H ; Tsuji S ; Minami N ; Hayashi S ; Noguchi S ; Iida A ; Nishino I ; Mori Yoshimura M ; Oya Y ; Ono K ; Shimizu T ; Kawata A ; Shimohama S ; Toyooka K ; Endo K ; Toru S ; Sasaki O ; Isahaya K ; Takahashi MP ; Iwasa K ; Kira JI ; Yamamoto T ; Kawamoto M ; Hamano T ; Sugie K ; Eura N ; Shiota T ; Koide M ; Sekiya K ; Kishi H ; Hideyama T ; Kawai S ; Yanagimoto S ; Sato H ; Arahata H ; Murayama S ; Saito K ; Hara H ; Kanda T ; Yaguchi H ; Imai N ; Kawagashira Y ; Sanada M ; Obara K ; Kaido M ; Furuta M ; Kurashige T ; Hara W ; Kuzume D ; Yamamoto M ; Tsugawa J ; Kishida H ; Ishizuka N ; Morimoto K ; Tsuji Y ; Tsuneyama A ; Matsuno A ; Sasaki R ; Tamakoshi D ; Abe E ; Yamada S ; Uzawa A | 28/05/2021Article
Aoki M ; Takahashi T | 27/05/2021Initial Posting: February 5, 2004; Last Update: May 27, 2021. Clinical characteristics. Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular [...]Article
Bayram N ; Bayram AK ; Per H ; Gumus H ; Ozsaygili C ; Dogan MS ; Caglayan AO | United States | 12/05/2021Article
Cervera-Gaviria M ; Enterría-Rosales J ; Juárez-Vignon-Whaley JJ ; García-Sánchez J ; Treviño-Velasco R ; Cervera-Gaviria J | 14/04/2021Article
Initial Posting: June 11, 2015; Last Update: April 8, 2021 Clinical description. Riboflavin transporter deficiency (RTD), comprising RTD2 and RTD3 (caused by biallelic pathogenic variants in SLC52A2 and SLC52A3, respectively) is a rare neu[...]Article
Foley AR ; Mohassel P ; Donkervoort S ; Bolduc V ; Bonnemann CG | 11/03/2021Initial Posting: June 25, 2004; Last Update: March 11, 2021. Clinical characteristics. Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, U[...]Article
Azzedine H ; Salih MA | 11/03/2021Initial Posting: March 31, 2008; Last Update: March 11, 2021. Clinical characteristics. SH3TC2-related hereditary motor and sensory neuropathy (SH3TC2-HMSN) is a demyelinating neuropathy characterized by severe spine deformities (scoliosis[...]Article
Article
Initial Posting: August 3, 2005; Last Update: February 25, 2021. Clinical characteristics. Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, faci[...]Article
Article
Moore U ; Gordish H ; Diaz-Manera J ; James MK ; Mayhew AG ; Guglieri M ; Fernandez Torron R ; Rufibach LE ; Feng J ; Blamire AM ; Carlier PG ; Spuler S ; Day JW ; Jones KJ ; Bharucha-Goebel DX ; Salort-Campana E ; Pestronk A ; Walter MC ; Paradas C ; Stojkovic T ; Mori Yoshimura M ; Bravver E ; Pegoraro E ; Lowes LP ; Mendell JR ; Bushby K ; Straub V | England | 21/01/2021Article
Velez-Bartolomei F ; Lee C ; Enns G | 07/01/2021Initial Posting: June 3, 2003; Last Update: January 7, 2021. Clinical characteristics. MERRF (myoclonic epilepsy with ragged red fibers) is a multisystem disorder characterized by myoclonus (often the first symptom) followed by generalized[...]Article
Prior TW ; Leach ME ; Finanger E | 3/12/2020Initial Posting: February 24, 2000; Last Revision: December 3, 2020. Clinical characteristics. Spinal muscular atrophy (SMA) is characterized by muscle weakness and atrophy resulting from progressive degeneration and irreversible loss of t[...]Article
Pipis M ; Feely SME ; Polke JM ; Skorupinska M ; Perez L ; Shy RR ; Laura M ; Morrow JM ; Moroni I ; Pisciotta C ; Taroni F ; Vujovic D ; Lloyd TE ; Acsadi G ; Yum SW ; Lewis RA ; Finkel RS ; Herrmann DN ; Day JW ; Li J ; Saporta M ; Sadjadi R ; Walk D ; Burns J ; Muntoni F ; Ramchandren S ; Horvath R ; Johnson NE ; Zuchner S ; Pareyson D ; Scherer SS ; Rossor AM ; Shy ME ; Reilly MM | 01/12/2020Article
Trollet C ; Boulinguiez A ; Roth F ; Stojkovic T ; Butler Browne G ; Evangelista T ; Lacau St Guily J ; Richard P | 22/10/2020Initial Posting: March 8, 2001; Last Update: October 22, 2020. Clinical characteristics. Oculopharyngeal muscular dystrophy (OPMD) is characterized by ptosis and dysphagia due to selective involvement of the muscles of the eyelids and phar[...]Article
McCray BA ; Schindler A ; Hoover-Fong JE ; Sumner CJ | 17/09/2020Initial Posting: May 15, 2014; Last Update: September 17, 2020. Clinical characteristics. The autosomal dominant TRPV4 disorders (previously considered to be clinically distinct phenotypes before their molecular basis was discovered) are n[...]Article
Initial Posting: April 2, 2009; Last Update: September 17, 2020. Clinical characteristics. Most individuals with classic GBE1 adult polyglucosan body disease (GBE1-APBD) present after age 40 years with unexplained progressive neurogenic bl[...]Article
Oliveira J ; Parente Freixo J ; Santos M ; Coelho T | 17/09/2020Initial Posting: June 7, 2012; Last Update: September 17, 2020. Clinical characteristics. The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy t[...]Article
Chrestian N | 27/08/2020Initial Posting: September 28, 1998; Last Update: August 27, 2020. Clinical characteristics. Hereditary neuropathy with liability to pressure palsies (HNPP) is characterized by recurrent acute sensory and motor neuropathy in a single or mu[...]Article
Ferreira C ; Pierre G ; Thompson R ; Vernon H | 09/07/2020nitial Posting: October 9, 2014; Last Update: July 9, 2020. Clinical characteristics. Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial ges[...]Article
Preethish Kumar V ; Shah A ; Kumar M ; Ingalhalikar M ; Polavarapu K ; Afsar M ; Rajeswaran J ; Vengalil S ; Nashi S ; Thomas PT ; Sadasivan A ; Warrier M ; Nalini A ; Saini J | 07/2020Article
Article
Prasun P | 18/06/2020Clinical characteristics. Multiple acyl-CoA dehydrogenase deficiency (MADD) represents a clinical spectrum in which presentations can be divided into type I (neonatal onset with congenital anomalies), type II (neonatal onset without congenita[...]Article
Samukawa M ; Nakamura N ; Hirano M ; Morikawa M ; Sakata H ; Nishino I ; Izumi R ; Suzuki N ; Kuroda H ; Shiga K ; Saigoh K ; Aoki M ; Kusunoki S | Switzerland | 06/2020Article
Cerino M ; Di Meglio C ; Albertini F ; Audic F ; Riccardi F ; Boulay C ; Philip N ; Bartoli M ; Levy N ; Krahn M ; Chabrol B | United States | 06/2020Article
Telese R ; Pagliarani S ; Lerario A ; Ciscato P ; Fagiolari G ; Cassandrini D ; Grimoldi N ; Conte G ; Cinnante C ; Santorelli FM ; Comi GP ; Sciacco M ; Peverelli L | United States | 06/2020Article
Hamanaka K ; Sikrova D ; Mitsuhashi S ; Masuda H ; Sekiguchi Y ; Sugiyama A ; Shibuya K ; Lemmers RJLF ; Goossens R ; Ogawa M ; Nagao K ; Obuse C ; Noguchi S ; Hayashi YK ; Kuwabara S ; Balog J ; Nishino I ; van der Maarel SM | United States | 06/2020Article
Stavusis J ; Micule I ; Wright NT ; Straub V ; Topf A ; Panades-de Oliveira L ; Dominguez Gonzalez C ; Inashkina I ; Kidere D ; Chrestian N ; Lace B | England | 06/2020Article
Zuchner S | 14/05/2020Initial Posting: February 18, 2005; Last Update: May 14, 2020. Clinical characteristics. MFN2 hereditary motor and sensory neuropathy (MFN2-HMSN) is a classic axonal peripheral sensorimotor neuropathy, inherited in either an autosomal domi[...]Article
Elsea SH ; Solyom A ; Martin K ; Harmatz P ; Mitchell J ; Lampe C ; Grant C ; Selim L ; Mungan NO ; Guelbert N ; Magnusson B ; Sundberg E ; Puri R ; Kapoor S ; Arslan N ; DiRocco M ; Zaki M ; Ozen S ; Mahmoud IG ; Ehlert K ; Hahn A ; Gokcay G ; Torcoletti M ; Ferreira CR | United States | 05/2020Article
Izumi R ; Takahashi T ; Suzuki N ; Niihori T ; Ono H ; Nakamura N ; Katada S ; Kato M ; Warita H ; Tateyama M ; Aoki Y ; Aoki M | United States | 05/2020Article
Article
Guimaraes-Costa R ; Villar-Quiles RN ; Latour P ; Sole G ; Husson I ; Lacour A ; Leonard-Louis S ; Stojkovic T | England | 05/2020Article
Article
Tasca G ; Lattante S ; Marangi G ; Conte A ; Bernardo D ; Bisogni G ; Mandich P ; Zollino M ; Ragozzino E ; Udd B ; Sabatelli M | England | 04/2020Article
Article
Abdel Aleem A ; Elsaid MF ; Chalhoub N ; Chakroun A ; Mohamed KAS ; AlShami R ; Kuzu O ; Mohamed RB ; Ibrahim K ; AlMudheki N ; Osman O ; Ross ME ; ELalamy O | England | 04/2020Article
Acta neuropathologica Intracellular calcium leak as a therapeutic target for RYR1-related myopathies
Kushnir A ; Todd JJ ; Witherspoon JW ; Yuan Q ; Reiken S ; Lin H ; Munce RH ; Wajsberg B ; Melville Z ; Clarke OB ; Wedderburn-Pugh K ; Wronska A ; Razaqyar MS ; Chrismer IC ; Shelton MO ; Mankodi A ; Grunseich C ; Tarnopolsky MA ; Tanji K ; Hirano M ; Riazi S ; Kraeva N ; Voermans NC ; Gruber A ; Allen C ; Meilleur KG ; Marks AR | Germany | 03/2020Article
Article
Bertrand AT ; Brull A ; Azibani F ; Benarroch L ; Chikhaoui K ; Stewart CL ; Medalia O ; Ben Yaou R ; Bonne G | Switzerland | 03/2020Article
Article
Harr JC ; Schmid CD ; Munoz-Jimenez C ; Romero-Bueno R ; Kalck V ; Gonzalez-Sandoval A ; Hauer MH ; Padeken J ; Askjaer P ; Mattout A ; Gasser SM | United States | 03/2020Article
Salort-Campana E ; Fatehi F ; Beloribi-Djefaflia S ; Roche S ; Nguyen K ; Bernard R ; Cintas P ; Sole G ; Bouhour F ; Ollagnon E ; Sacconi S ; Echaniz-Laguna A ; Kuntzer T ; Levy N ; Magdinier F ; Attarian S | Switzerland | 03/2020Article
Article
Sullivan JM ; Motley WW ; Johnson JO ; Aisenberg WH ; Marshall KL ; Barwick KE ; Kong L ; Huh JS ; Saavedra-Rivera PC ; McEntagart MM ; Marion MH ; Hicklin LA ; Modarres H ; Baple EL ; Farah MH ; Zuberi AR ; Lutz CM ; Gaudet R ; Traynor BJ ; Crosby AH ; Sumner CJ | United States | 03/2020Article
Preston MK ; Tawil R ; Wang LH | 06/02/2020Initial Posting: March 8, 1999; Last Update: February 6, 2020. Clinical characteristics. Facioscapulohumeral muscular dystrophy (FSHD) typically presents with weakness of the facial muscles, the stabilizers of the scapula, or the dorsiflexor[...]Article
Article
Article
Article
Lee HH ; Wong S ; Sheng B ; Pan NK ; Leung YF ; Lau KD ; Cheng YS ; Ho LC ; Li R ; Lee CN ; Tsoi TH ; Cheung YN ; Fu YM ; Kan NA ; Chu YP ; Au WL ; Yeung HJ ; Li SH ; Cheung CM ; Tong HF ; Hung LE ; Chan TY ; Li CT ; Tong TT ; Tong TC ; Leung HC ; Lee KH ; Yeung SS ; Lee SB ; Lau TG ; Lam CW ; Mak CM ; Chan AY | Denmark | 02/2020Article
Zanoteli E ; Soares PS ; Silva AMSD ; Camelo CG ; Fonseca ATQSM ; Albuquerque MAV ; Moreno CAM ; Lopes Abath Neto O ; Novo Filho GM ; Kulikowski LD ; Reed UC | Netherlands | 02/2020Article
Frasquet M ; Camacho A ; Vilchez R ; Argente-Escrig H ; Millet E ; Vazquez-Costa JF ; Silla R ; Sánchez-Monteagudo A ; Vilchez JJ ; Espinos C ; Lupo V ; Sevilla T | England | 02/2020Article
Article
Article
Article
Article
Ishihara S ; Okamoto Y ; Tanabe H ; Yoshimura A ; Higuchi Y ; Yuan JH ; Hashiguchi A ; Ishiura H ; Mitsui J ; Suwazono S ; Oya Y ; Sasaki M ; Nakagawa M ; Tsuji S ; Ohya Y ; Takashima H | United States | 02/2020Article
Rosenberg H ; Sambuughin N ; Riazi S ; Dirksen R | 16/01/2020Initial Posting: December 19, 2003; Last Update: January 16, 2020. Clinical characteristics. Malignant hyperthermia susceptibility (MHS) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated with uncontrolled skeleta[...]Article
Villar-Quiles RN ; Catervi F ; Cabet E ; Juntas-Morales R ; Genetti CA ; Gidaro T ; Koparir A ; Yuksel A ; Coppens S ; Deconinck N ; Pierce-Hoffman E ; Lornage X ; Durigneux J ; Laporte J ; Rendu J ; Romero NB ; Beggs AH ; Servais L ; Cossee M ; Olive M ; Bohm J ; Duband-Goulet I ; Ferreiro A | United States | 2020Article
Pellerin D ; Aykanat A ; Ellezam B ; Troiano EC ; Karamchandani J ; Dicaire MJ ; Petitclerc M ; Robertson R ; Allard-Chamard X ; Brunet D ; Konersman CG ; Mathieu J ; Warman-Chardon J ; Gupta VA ; Beggs AH ; Brais B ; Chrestian N | United States | 01/2020Article
Danhelovska T ; Kolarova H ; Zeman J ; Hansikova H ; Vaneckova M ; Lambert L ; Kucerova-Vidrova V ; Berankova K ; Honzik T ; Tesarova M | England | 01/2020Article
Alonso Perez J ; Gonzalez-Quereda L ; Bello L ; Guglieri M ; Straub V ; Gallano P ; Semplicini C ; Pegoraro E ; Zangaro V ; Nascimento A ; Ortez C ; Comi GP ; Dam LT ; de Visser M ; van der Kooi AJ ; Garrido C ; Santos M ; Schara U ; Gangfus A ; Lokken N ; Storgaard JH ; Vissing J ; Schoser B ; Dekomien G ; Udd B ; Palmio J ; D'Amico A ; Politano L ; Nigro V ; Bruno C ; Panicucci C ; Sarkozy A ; Abdel Mannan O ; Alonso-Jimenez A ; Claeys KG ; Gomez-Andres D ; Munell F ; Costa-Comellas L ; Haberlova J ; Rohlenova M ; Elke V ; De Bleecker JL ; Dominguez Gonzalez C ; Tasca G ; Weiss C ; Deconinck N ; Fernandez Torron R ; Lopez de Munain A ; Camacho-Salas A ; Melegh B ; Hadzsiev K ; Leonardis L ; Koritnik B ; Garibaldi M ; de Leon-Hernandez JC ; Malfatti E ; Fraga-Bau A ; Richard I ; Illa I ; Diaz-Manera J | England | 2020Article
Article
Spitali P ; Zaharieva I ; Böhringer S ; Hiller M ; Chaouch A ; Roos A ; Scotton C ; Claustres M ; Bello L ; McDonald CM ; Hoffman EP ; Koeks Z ; Eka Suchiman H ; Cirak S ; Scoto M ; Reza M ; 't Hoen PAC ; Niks EH ; Tuffery-Giraud S ; Lochmuller H ; Ferlini A ; Muntoni F ; Aartsma Rus A | England | 01/2020Article
Hellebrekers DMJ ; Doorenweerd N ; Sweere DJJ ; van Kuijk SMJ ; Aartsma Rus AM ; Klinkenberg S ; Vles JSH ; Hendriksen JGM | England | 01/2020Article
Article
Akesson LS ; Savarirayan R | 2020Clinical characteristics. Fibrodysplasia ossificans progressiva (FOP) is characterized by congenital bilateral hallux valgus malformations and early-onset heterotopic ossification, which may be spontaneous or precipitated by trauma including [...]Article
Landires I ; Nunez-Samudio V ; Fernandez J ; Sarria C ; Villareal V ; Cordoba F ; Apraez-Ippolito G ; Martinez S ; Vidal OM ; Velez JI ; Arcos-Holzinger M ; Landires S ; Arcos-Burgos M | Switzerland | 01/2020Article
Morales F ; Vasquez M ; Corrales E ; Vindas-Smith R ; Santamaria-Ulloa C ; Zhang B ; Sirito M ; Estecio MR ; Krahe R ; Monckton DG | England | 2020Article
Article
Nagappa M ; Sharma S ; Govindaraj P ; Chickabasaviah YT ; Siram R ; Shroti A ; Debnath M ; Sinha S ; Bindu PS ; Taly AB | United States | 01/2020Article
Waldrop MA ; Yaou RB ; Lucas KK ; Martin AS ; O'Rourke E ; Ferlini A ; Muntoni F ; Leturcq F ; Tuffery-Giraud S ; Weiss RB ; Flanigan KM | Netherlands | 2020Article
Evangelista T ; Lornage X ; Carlier PG ; Bassez G ; Brochier G ; Chanut A ; Lacene E ; Bui MT ; Metay C ; Oppermann U ; Bohm J ; Laporte J ; Romero NB | England | 2020Article
Article
Darmahkasih AJ ; Rybalsky I ; Tian C ; Shellenbarger KC ; Horn PS ; Lambert JT ; Wong BL | United States | 01/2020Article
Article
Preiksaitiene E ; Voisin N ; Gueneau L ; Benusiene E ; Krasovskaja N ; Blazyte EM ; Ambrozaityte L ; Rancelis T ; Reymond A ; Kucinskas V | United States | 12/2019Article
Article
Article
Article
Article
Article
Article
De Ridder W ; Azmi A ; Clemen CS ; Eichinger L ; Hofmann A ; Schröder R ; Johnson K ; Topf A ; Straub V ; De Jonghe P ; Maudsley S ; De Bleecker JL ; Baets J | United States | 12/2019Article
Hedberg-Oldfors C ; De Ridder W ; Kalev O ; Bock K ; Visuttijai K ; Caravias G ; Topf A ; Straub V ; Baets J ; Oldfors A | England | 12/2019Article
Labrador E ; Weinstein DA | 27/11/2019Initial Posting: April 23, 2009; Last Update: November 27, 2019. Clinical characteristics. Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzy[...]Article
Des mutations récessives dans le gène PYROXD1 ont été récemment décrites chez des patients présentant un tableau de myopathie congénitale ou de dystrophie musculaire des ceintures [1-4]. PYROXD1 (PYRidine nucleotide-disulfide OXidoreductase Doma[...]Article
Viggiano E, Auteur ; Madej-Pilarczyk A ; Carboni N ; Picillo E ; Ergoli M ; Gaudio SD ; Marchel M ; Nigro G ; Palladino A ; Politano L | Switzerland | 11/2019Article
Article
Llavero F ; Arrazola Sastre A ; Luque Montoro M ; Galvez P ; Lacerda HM ; Parada LA ; Zugaza JL | Switzerland | 11/2019Article
Chong-Nguyen C ; Stalens C ; Goursot Y ; Bougouin W ; Stojkovic T ; Behin A ; Mochel F ; Berber N ; Eymard B ; Duboc D ; Laforet P ; Wahbi K | United States | 11/2019Article
Article
Gonzalez-del Angel A, Auteur ; Bisciglia M ; Vargas-Canas S ; Fernandez-Valverde F ; Kazakova E ; Escobar RE ; Romero NB ; Jardel C ; Rucheton B ; Stojkovic T ; Malfatti E | Switzerland | 10/2019Article
Wang H, Auteur ; Kacar Bayram A ; Sprute R ; Ozdemir O ; Cooper E ; Pergande M ; Efthymiou S ; Nedic I ; Mazaheri N ; Stumpfe K ; Azizi Malamiri R ; Shariati G ; Zeighami J ; Bayram N ; Naghibzadeh SK ; Tajik M ; Yasar M ; Sami Guven A ; Bibi F ; Sultan T ; Salpietro V ; Houlden H ; Per H ; Galehdari H ; Shalbafan B ; Jamshidi Y ; Cirak S | Switzerland | 10/2019Article
Article
Article
Thangarajh M, Auteur ; Hendriksen J ; McDermott MP ; Martens W ; Hart KA ; Griggs RC | United States | 10/2019Article
Article
Kimonis V | 12/09/2019Initial Posting: May 25, 2007; Last Update: September 12, 2019. Clinical characteristics. Inclusion body myopathy associated with Paget disease of bone (PDB) and/or frontotemporal dementia (IBMPFD) is characterized by adult-onset proximal [...]Article
Gigli M ; Merlo M ; Graw SL ; Barbati G ; Rowland TJ ; Slavov DB ; Stolfo D ; Haywood ME ; Dal Ferro M ; Altinier A ; Ramani F ; Brun F ; Cocciolo A ; Puggia I ; Morea G ; McKenna WJ ; La Rosa FG ; Taylor MRG ; Sinagra G ; Mestroni L | United States | 09/2019Article
Bonne G ; Leturcq F ; Ben Yaou R | 15/08/2019Initial Posting: September 29, 2004; Last Update: August 15, 2019. Clinical characteristics. Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progr[...]Article
Article
Saito K | 03/07/2019Initial Posting: January 26, 2006; Last Update: July 3, 2019. Clinical characteristics. Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that[...]Article
Lerat J, Auteur ; Magdelaine C ; Lunati A ; Dzugan H ; Dejoie C ; Rego M ; Beze Beyrie P ; Bieth E ; Calvas P ; Cintas P ; Delaubrier A ; Demurger F ; Gilbert-Dussardier B ; Goizet C ; Journel H ; Laffargue F ; Magy L ; Taithe F ; Toutain A ; Urtizberea JA ; Sturtz F ; Lia AS | Netherlands | 06/2019Article
Wieser T | 03/01/2019Initial Posting: August 27, 2004; Last Revision: January 3, 2019. Clinical characteristics. Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal n[...]Article
El-Hattab AW ; Almannai M ; Scaglia F | 29/11/2018Initial Posting: February 27, 2001; Last Update: November 29, 2018. Clinical characteristics. MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is a multisystem disorder with protean manifestations. The vast [...]Article
Herbert M ; Goldstein JL ; Rehder C ; Austin S ; Kishnani PS ; Bali DS | 01/11/2018Initial Posting: May 31, 2011; Last Update: November 1, 2018. Clinical characteristics. Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, whi[...]Article
Article
Dowling JJ ; Lawlor MW ; Das S | 23/08/2018Initial Posting: February 25, 2002; Last Update: August 23, 2018. Clinical characteristics. X-linked myotubular myopathy (X-MTM), also known as myotubular myopathy (MTM), is characterized by muscle weakness that ranges from severe to mild. [...]Article
Wolfe L ; Jethva R ; Oglesbee D ; Vockley J | 09/08/2018Initial Posting: September 22, 2011; Last Update: August 9, 2018. Clinical characteristics. Most infants with short-chain acyl-CoA dehydrogenase deficiency (SCADD) identified through newborn screening programs have remained well, and asympto[...]Article
Weber F ; Lehmann-Horn F | 26/07/2018Initial Posting: April 30, 2002; Last Update: July 26, 2018. Clinical characteristics. Hypokalemic periodic paralysis (hypoPP) is a condition in which affected individuals may experience paralytic episodes with concomitant hypokalemia (ser[...]Article
Wang J ; El-Hattab AW | 26/07/2018Initial Posting: December 6, 2012; Last Update: July 26, 2018. Clinical characteristics. TK2-related mitochondrial DNA (mtDNA) maintenance defect is a phenotypic continuum that ranges from severe to mild. To date, approximately 107 individua[...]Article
Veerapandiyan A ; Statland JM ; Tawil R | 07/06/2018Initial Posting: November 22, 2004; Last Update: June 7, 2018. Clinical characteristics. Andersen-Tawil syndrome (ATS) is characterized by a triad of: episodic flaccid muscle weakness (i.e., periodic paralysis); ventricular arrhythmias and p[...]Article
Owen D, Auteur ; Topf A ; Preethish Kumar V ; Lorenzoni PJ ; Vroling B ; Scola RH ; Dias-Tosta E ; Geraldo A ; Polavarapu K ; Nashi S ; Cox D ; Evangelista A ; Dawson J ; Thompson R ; Senderek J ; Laurie S ; Beltran S ; Gut M ; Gut I ; Nalini A ; Lochmuller H | 28/04/2018Article
Tome S, Auteur ; Dandelot E ; Dogan C ; Bertrand A ; Genevieve D ; Pereon Y ; Simon M ; Bonnefont JP ; Bassez G ; Gourdon G | 17/04/2018Article
Ivanov I, Auteur ; Atkinson D ; Litvinenko I ; Angelova L ; Andonova S ; Mumdjiev H ; Pacheva I ; Panova M ; Yordanova R ; Belovejdov V ; Petrova A ; Bosheva M ; Shmilev T ; Savov A ; Jordanova A | 03/04/2018Article
Article
DA Dyment ; Bennett SAL ; Medin JA ; Levade T | 29/03/2018Initial Posting: March 29, 2018. Clinical characteristics. The spectrum of ASAH1-related disorders ranges from Farber disease (FD) to spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME). Classic FD is characterized b[...]Article
Mori Yoshimura M, Auteur ; Mitsuhashi S ; Nakamura H ; Komaki H ; Goto K ; Yonemoto N ; Takeuchi F ; Hayashi YK ; Murata M ; Takahashi Y ; Nishino I ; Takeda S ; Kimura E | 26/03/2018Article
Traverso M, Auteur ; Assereto S ; Baratto S ; Iacomino M ; Pedemonte M ; Diana MC ; Ferretti M ; Broda P ; Minetti C ; Gazzerro E ; Madia F ; Bruno C ; Zara F ; Fiorillo C | 19/03/2018Article
Saghira C, Auteur ; Bis DM ; Stanek D ; Strickland A ; Herrmann DN ; Reilly MM ; Scherer SS ; Shy ME ; Zuchner S | 22/02/2018Article
Al-Obeidi E, Auteur ; Al-Tahan S ; Surampalli A ; Goyal N ; Wang A ; Hermann A ; Omizo M ; Smith C ; Mozaffar T ; Kimonis V | 2018Article
Article
Harris E, Auteur ; Marini Bettolo C ; Topf A ; Barresi R ; Polvikovski T ; Bailey G ; Charlton R ; Tellez J ; Macarthur D ; Guglieri M ; Lochmuller H ; Bushby K ; Straub V | 2018Article
Pogoryelova O, Auteur ; Cammish P ; Mansbach H ; Argov Z ; Nishino I ; Skrinar A ; Chan Y ; Nafissi S ; Shamshiri H ; Kakkis E ; Lochmuller H | 2018Article
Calucho M, Auteur ; Bernal S ; Alias L ; March F ; Vencesla A ; Rodriguez-Alvarez FJ ; Aller E ; Fernandez RM ; Borrego S ; Millan JM ; Hernandez-Chico C ; Cusco I ; Fuentes-Prior P ; Tizzano EF | 2018Article
Fayssoil A, Auteur ; Ben Yaou R ; Ogna A ; Chaffaut C ; Leturcq F ; Nardi O ; Wahbi K ; Duboc D ; Lofaso F ; Prigent H ; Clair B ; Crenn P ; Nicolas G ; Laforet P ; Behin A ; Chevret S ; Orlikowski D ; Annane D | 2018Article
El-Hattab AW ; Scaglia F | 18/05/2017Initial Posting: May 26, 2009; Last Revision: May 18, 2017. Clinical characteristics. SUCLA2-related mitochondrial DNA (mtDNA) depletion syndrome, encephalomyopathic form with methylmalonic aciduria is characterized by onset of the following[...]Article
Bird TD | 30/03/2017Initial Posting: May 11, 2004; Last Update: March 30, 2017. Clinical characteristics. GDAP1-related hereditary motor and sensory neuropathy (GDAP1-HMSN) is a peripheral neuropathy (also known as a subtype of Charcot-Marie-Tooth disease) th[...]Article
Rothwell S, Auteur ; Cooper RG ; Lundberg IE ; Gregersen PK ; Hanna MG ; Machado PM ; Herbert MK ; Pruijn GJ ; Lilleker JB ; Roberts M ; Bowes J ; Seldin MF ; Vencovsky J ; Danko K ; Limaye V ; Selva-O Callaghan A ; Platt H ; Molberg Ø ; Benveniste O ; Radstake TR ; Doria A ; De Bleecker J ; de Paepe B ; Gieger C ; Meitinger T ; Winkelmann J ; Amos CI ; Ollier WE ; Padyukov L ; Lee AT ; Lamb JA ; Chinoy H | 2017Comment in: Inflammatory myopathies: Genetic associations with IBM. [Nat Rev Rheumatol. 2017]Article
Santalla A, Auteur ; Nogales Gadea G ; Encinar AB ; Viéitez I ; Gonzalez-Quintana A ; Serrano-Lorenzo P ; Consuegra IG ; Asensio S ; Ballester-Lopez A ; Pintos-Morell G ; Coll-Cantí J ; Pareja-Galeano H ; Diez-Bermejo J ; Perez M ; Andreu AL ; Pinos T ; Arenas J ; Martin MA ; Lucia A | 2017Article
Deepha S, Auteur ; Vengalil S ; Preethish Kumar V ; Polavarapu K ; Nalini A ; Gayathri N ; Purushottam M | 2017Article
van Dijk T, Auteur ; Rudnik Schoneborn S ; Senderek J ; Hajmousa G ; Mei H ; Dusl M ; Aronica E ; Barth P ; Baas F | 2017Article
Chong-Nguyen C, Auteur ; Wahbi K ; Algalarrondo V ; Bécane HM ; Radvanyi-Hoffman H ; Arnaud P ; Furling D ; Lazarus A ; Bassez G ; Behin A ; Fayssoil A ; Laforet P ; Stojkovic T ; Eymard B ; Duboc D | 2017Comment in: Repeats and Survival in Myotonic Dystrophy Type 1. [Circ Cardiovasc Genet. 2017]Article
Wheeler MT, Auteur | 2017Comment on: Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry. [Circ Cardiovasc Genet. 2017]Article
Vengalil S, Auteur ; Preethish Kumar V ; Polavarapu K ; Mahadevappa M ; Sekar D ; Purushottam M ; Thomas PT ; Nashi S ; Nalini A | 2017Article
Nakamura A, Auteur ; Shiba N ; Miyazaki D ; Nishizawa H ; Inaba Y ; Fueki N ; Maruyama R ; Echigoya Y ; Yokota T | 2017Article
Article
Richard P, Auteur ; Trollet C ; Stojkovic T ; de Becdelievre A ; Perie S ; Pouget J ; Eymard B | 2017Article
Ben Yaou R, Auteur ; Hubert A ; Nelson I ; Dahlqvist JR ; Gaist D ; Streichenberger N ; Beuvin M ; Krahn M ; Petiot P ; Parisot F ; Michel F ; Malfatti E ; Romero NB ; Carlier RY ; Eymard B ; Labrune P ; Duno M ; Krag T ; Cerino M ; Bartoli M ; Bonne G ; Vissing J ; Laforet P ; Petit FM | 2017Article
Pane M, Auteur ; Lapenta L ; Abiusi E ; De Sanctis R ; Luigetti M ; Palermo C ; Ranalli D ; Fiori S ; Tiziano FD ; Mercuri E | 2017Article
Moreno CAM, Auteur ; Abath Neto O ; Donkervoort S ; Hu Y ; Reed UC ; Oliveira ASB ; Bonnemann C ; Zanoteli E | 2017Article
Rossi D, Auteur ; Palmio J ; Evila A ; Galli L ; Barone V ; Caldwell TA ; Policke RA ; Aldkheil E ; Berndsen CE ; Wright NT ; Malfatti E ; Brochier G ; Pierantozzi E ; Jordanova A ; Guergueltcheva V ; Romero NB ; Hackman P ; Eymard B ; Udd B ; Sorrentino V | 2017Article
Barp A, Auteur ; Bello L ; Caumo L ; Campadello P ; Semplicini C ; Lazzarotto A ; Soraru G ; Calore C ; Rampado A ; Motta R ; Stramare R ; Pegoraro E | 2017Article
Bello L ; Campadello P ; Barp A ; Fanin M ; Semplicini C ; Soraru G ; Caumo L ; Calore C ; Angelini C ; Pegoraro E | 09/2016Article
Hershberger RE ; Morales A | 07/07/2016Initial Posting: June 12, 2008; Last Update: July 7, 2016. Clinical characteristics. LMNA-related dilated cardiomyopathy (DCM) is caused by pathogenic variants in LMNA and is characterized by left ventricular enlargement and/or reduced systo[...]Article
Ben Yaou R, Auteur ; Nicolas A, Auteur ; Le Rumeur E, Auteur ; Leturq F, Auteur | EDP Sciences | 06/2016Article
Bird TD | 14/04/2016Initial Posting: September 24, 1998; Last Revision: April 14, 2016. NOTE: THIS PUBLICATION IS ARCHIVED. IT IS FOR HISTORICAL REFERENCE ONLY, AND THE INFORMATION MAY BE OUT OF DATE. Clinical characteristics. Charcot-Marie-Tooth hereditary [...]Article
Bird TD | 14/04/2016Initial Posting: September 24, 1998; Last Revision: April 14, 2016. NOTE: THIS PUBLICATION IS ARCHIVED. IT IS FOR HISTORICAL REFERENCE ONLY, AND THE INFORMATION MAY BE OUT OF DATE. Clinical characteristics. Charcot-Marie-Tooth neuropathy [...]Article
Initial Posting: March 31, 2009; Last Update: March 3, 2016. Clinical characteristics. Myopathy with deficiency of ISCU, a mitochondrial myopathy, is classically characterized by lifelong exercise intolerance in which minor exertion causes t[...]Article
5th International Congress of Myology (14-18 March 2016; Centre convention, Lyon, France), Collectivité éditrice | AFM-TELETHON | 03/2016Article
5th International Congress of Myology (14-18 March 2016; Centre convention, Lyon, France), Collectivité éditrice | AFM-TELETHON | 03/2016Article
5th International Congress of Myology (14-18 March 2016; Centre convention, Lyon, France), Collectivité éditrice | AFM-TELETHON | 03/2016Article
5th International Congress of Myology (14-18 March 2016; Centre convention, Lyon, France), Collectivité éditrice | AFM-TELETHON | 03/2016Article
van den Boogaard ML, Auteur ; Lemmers RJLF ; Balog J ; Wohlgemuth M ; Auranen M ; Mitsuhashi S ; van der Vliet PJ ; Straasheijm KR ; van den Akker RF ; Kriek M ; Laurense-Bik ME ; Raz V ; van Ostaijen-Ten Dam MM ; Hansson KB ; van der Kooi EL ; Kiuru-Enari S ; Udd B ; van Tol MJ ; Nishino I ; Tawil R ; Tapscott SJ ; van Engelen BG ; van der Maarel SM | 2016Article
Tasca G, Auteur ; Monforte M ; Ottaviani P ; Pelliccioni M ; Frusciante R ; Laschena F ; Ricci E | 2016Article
Nikolic A, Auteur ; Ricci G ; Sera F ; Bucci E ; Govi M ; Mele F ; Rossi M ; Ruggiero L ; Vercelli L ; Ravaglia S ; Brisca G ; Fiorillo C ; Villa L ; Maggi L ; Cao M ; D'Amico MC ; Siciliano G ; Antonini G ; Santoro L ; Mongini T ; Moggio M ; Morandi L ; Pegoraro E ; Angelini C ; Di Muzio A ; Rodolico C ; Tomelleri G ; Grazia D'Angelo M ; Bruno C ; Berardinelli A ; Tupler R | 2016Article
Article
Wan J, Auteur ; Steffen J ; Yourshaw M ; Mamsa H ; Andersen E ; Rudnik Schoneborn S ; Pope K ; Howell KB ; McLean CA ; Kornberg AJ ; Joseph J ; Lockhart PJ ; Zerres K ; Ryan MM ; Nelson SF ; Koehler CM ; Jen JC | 2016Article
Vissing J, Auteur ; Barresi R ; Witting N ; van Ghelue M ; Gammelgaard L ; Bindoff LA ; Straub V ; Lochmuller H ; Hudson J ; Wahl CM ; Arnardottir S ; Dahlbom K ; Jonsrud C ; Duno M | 2016Comment in: Dominant LGMD2A: alternative diagnosis or hidden digenism? [Brain. 2017] Reply: Dominant LGMD2A: alternative diagnosis or hidden digenism? [Brain. 2017]